The "Checkpoint Inhibitor Refractory Cancer Drugs Market -- Growth, Share, Opportunities & Competitive Analysis, 2025 -- 2032" report has been added to the Credence Research Inc. offering. The global ...

How to Help Men Last Longer This article was reviewed by Kelly Brown MD, MBA. Want your guy to last longer during intimacy? You’re not alone.

Of all the baseless fitness myths to have been peddled through ages of infomercials and influencers alike, the notion that you can “blast belly fat” is among the most audacious. Targeted fat loss, or ...

Taylor Leamey wrote about all things wellness for CNET, specializing in mental health, sleep and nutrition coverage. She has invested hundreds of hours into studying and researching sleep and holds a ...

Consider the case of patient WB, a 79-year-old male with recurrent diffuse large B cell lymphoma. He was referred for ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today reported financial ...

The "Checkpoint Inhibitor Refractory Cancer Drugs Market - Growth, Share, Opportunities & Competitive Analysis, 2025 - 2032" report has been added to the ...

The CD19 inhibitors market is projected to expand substantially in the coming years. This growth is driven by a rising number of patients diagnosed with ...

G&A Expenses -- $13.8 million in the fourth quarter, of which $5.6 million was non-cash stock-based compensation; annual G&A ...

Earnings call Legend Biotech posted 64% year-over-year revenue growth in Q4 2025, propelled by CARVYKTI’s expanding market share and manufacturing scale. Gross margin stabilized at 61%, and the ...

The survey conducted by AAHA and Gallant found 95% of industry professionals think stem cell therapy will become a new spectrum of care standard treatment option within 10 years. The American Animal ...

The CD19 inhibitors market is projected to expand substantially in the coming years. This growth is driven by a rising number of patients diagnosed with conditions such as NHL, ALL, NMOSD, IgG4-RD ...